High Expression of Epidermal Growth Factor Receptor Might Predict Poor Survival in Patients with Colon Cancer: A Meta-Analysis
- 1 April 2013
- journal article
- research article
- Published by Mary Ann Liebert Inc in Genetic Testing and Molecular Biomarkers
- Vol. 17 (4), 348-351
- https://doi.org/10.1089/gtmb.2012.0421
Abstract
Background and Aims: The epidermal growth factor receptor (EGFR) has been recognized as a molecular target for antibody-based therapy in various cancer types. Here we aimed to analyze the relation between high expression of EGFR and postoperational survival in patients with colon cancer. Methods: A meta-analysis was performed by searching PubMed, Cochrane Library, EMBASE, and Science Direct databases from 1960 to June 2012. Data were extracted from studies comparing survival in colon cancer patients having higher EGFR expression with those having lower levels. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated. Results: Four studies including 815 colon cancer patients were subjected to final analysis. Comparing to patients with low expression of EGFR, the HR of postoperational survival for patients with high EGFR expression was 2.34 (95% CI: 1.83–2.99), which could significantly predict poorer survival. Conclusions: High expression of EGFR might predict poor survival for patients with colon cancer.Keywords
This publication has 21 references indexed in Scilit:
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase InhibitorsGastroenterology, 2012
- From Chemotherapy to Targeted Therapy in Adjuvant Treatment for Stage III Colon CancerSeminars in Oncology, 2011
- Clinical impact of anti‐epidermal growth factor receptor monoclonal antibodies in first‐line treatment of metastatic colorectal cancerCancer, 2011
- Angiogenesis-related molecular targets in esophageal cancerExpert Opinion on Investigational Drugs, 2011
- The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomasExpert Opinion on Biological Therapy, 2010
- Increased epidermal growth factor receptor expression at the invasive margin is a negative prognostic factor in colorectal cancerInternational Journal of Cancer, 2010
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon CancerJournal of Clinical Oncology, 2009
- Prognostic Significance of Epidermal Growth Factor Receptor Expression in Colon Cancer Patients Undergoing Curative SurgeryAnnals of Surgical Oncology, 2006
- Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinomaCancer, 2003
- Travoprost: A potent ocular hypotensive agentDrugs of Today, 2003